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OBJECTIVES:
In recent years, increasing efforts have been dedicated to assess the health-related quality of life (HRQL) in people infected with tuberculosis (TB). A variety of generic instruments exist to assess quality of life (QoL) in TB patients, but a psychometrically sound TB-specific HRQL instrument is lacking. The current study aimed to develop a self-reported HRQL measure specific for pulmonary TB patients in Iraq. METHODS: The core, general HRQL questionnaire is comprised of the Functional Assessment of Cancer Therapy-General (FACT-G) items. The FACT-G was selected because of its established psychometrics and history in measuring HRQL symptoms in patients with a variety of chronic illnesses. A modular approach was followed for the development of Functional Assessment of Chronic Illness Therapy-Tuberculosis (FACIT-TB) questionnaire in which a set of items assessing QoL issues not sufficiently covered by the core FACT-G items, but considered to be relevant to the target population, were added. The development process of an additional concerns subscale of the FACIT-TB instrument consisted of several stages, including: 1) Concept clarification; 2) Item pool generation; 3) Item reduction; 4) Refinement. RESULTS: In addition to the 27 items of the core questionnaire, a set of 20 items referring to disease symptoms related to the site of infection (Pulmonary TB); side effects and other issues related to treatment; and additional QoL dimensions such as fatigue, fear of disease transmission, and economic burden of the illness were included in the additional subscale of FACIT-TB. CONCLUSIONS: A rigorous method was applied in the development of FACIT-TB to fully understand the impact of the illness on QoL of TB patients. However, further linguistic validation and psychometric testing should be conducted to ensure conceptual equivalence, validity and reliability of the instrument and its relevance among Arabic-speaking patients in Iraq. 
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IMPACT OF PHARMACISTS LED HEALTH EDUCATION PROGRAMME ON HEALTH-RELATED QUALITY OF LIFE IN PAKISTANI HEPATITIS-B PATIENTS
OBJECTIVES:
The study evaluated the impact of a health educational intervention in improvement of health related quality of life (HRQoL) in Pakistani Hepatitis-B patients. METHODS: A non-clinical randomized control trial was conducted. Hepatitis B patients received an educational intervention through hospital pharmacists who provided them with information about Hepatitis-B treatment and management and improvement of HRQoL. Health Related Quality of Life was measured by Euroqol (EQ-5D). Descriptive statistics were used to describe the demographic characteristics of the patients. Inferential statistics (Chi square test, Mann-Whitney U test) were used for inter-group comparison. The intra-group comparison was performed by Wilcoxon Rank Sum test. SPSS 17.0 was used for data analysis. RESULTS: Three hundred and ninety Hepatitis-B patients were randomly assigned to the study [195 in each group i.e. control group (CG) and the intervention group (IG)]. No significant differences were observed in either group for mean age, gender, education, occupation, income and locality. There was significant (p<0.001) increase in EQ-5D score from 0.3498±0.3178 to 0.4739±0.2624 (in post interventional intervention group). The results revealed non-statistical significant (p=0.563) between the Interventional group (0.4726±0.2522) and control group (0.4745±0.2791) among overall HRQoL scores. CONCLUSIONS: The pharmacist-focused intervention led to a significant increase in the patient's health related quality of life. Therefore, the role of pharmacists in patient education must be formalized and acknowledged as an official part of the health care system. (2009) (2010) (2011) (2012) (2013) and examine the impact universal policies have had on performance. METHODS: A secure website was used to report monthly HCP vaccination rates by each participating hospital. Overall and individual hospital performance was publicly reported each month. Statistical analysis was performed to compare the HCP vaccination rate before and after adoption of a universal policy to compare HCP vaccination rate by policy type for each month of the flu season. RESULTS: In the first two seasons, there were 11 hospitals reporting with an average end of season rate of 76% (2009) (2010) and 81% (2010-2011) . In the 2011-2012 season, there were 22 hospitals reporting, 9 of which had a new universal policy for HCP influenza vaccination. The average 2011-2012 end of season rate was 72% for hospitals with a voluntary program and 95% for hospitals with a universal policy. HCP were also vaccinated earlier in the influenza season when a universal policy was in place, providing greater benefit over time. We found that there was a statistically significant difference in vaccination rate by type of policy at both the beginning of the influenza season and at the end of the influenza season. In the 2012-2013 season, there are 34 hospitals voluntary participating which reflects a huge increase in terms of public reporting of HCP influenza vaccinations; updated results will be presented. CONCLUSIONS: A variety of factors may contribute to the rate of hospital HCP influenza vaccination. Public reporting of HCP influenza vaccination rates may contribute to implementation of universal employee vaccination policies. Hospitals with universal policies have higher vaccination rates than those with voluntary vaccination programs. Our study has demonstrated that implementation of a universal policy contributes to a dramatic increase in performance. OBJECTIVES: Community-acquired pneumonia (CAP) is one of the leading causes of death due to infection and a primary indication for antibiotic therapy. Multiple guidelines exist for recommending initial antibiotic choice for treatment of CAP. This study was conducted to evaluate the trends in antibiotic choice for treatment of CAP in hospitalized patients (non-ICU) at a tertiary care center, Safdarjung Hospital, Delhi, India. METHODS: A retrospective medical record review of hospitalized adult patients discharged to home (mean hospital stay 5.38 days (SD=2.97)) with a diagnosis of CAP in 2007 (n=139) and 2011 (n=142) was performed. A standardized form was completed by a trained medical resident.
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PIN92 ANTIBIOTIC PRESCRIBING PATTERNS FOR COMMUNITY ACQUIRED PNEUMONIA IN HOSPITALIZED PATIENTS: A RETROSPECTIVE PILOT STUDY FROM DELHI, INDIA
RESULTS:
The pattern of antibiotic use in 2007 and 2011, respectively, wasmonotherapy 30.2% versus 21.1%; combination of two antibiotics 61.1% versus 65.5%; and combination of three antibiotics 8.6% versus 13.3%. Amoxicillin+clavulanic acid or ceftriaxone (β-lactam antibiotics) were most frequently used as monotherapy in both 2007 (80.9% and 9.5%) and 2011 (56.7% and 36.7%) The study indicates that third generation cephalosporins and piperacillin+tazobactam use at the study hospital is increasing, whereas amoxicillin+clavulanic acid use is decreasing in non-ICU hospitalized patients with CAP. This trend is not in accordance with published guidelines and especially concerning in light of emerging antimicrobial resistance. 
PIN93 SURVEY OF ANTIMALARIAL DRUGS PRICES AND AVAILABILITY IN RETAIL OUTLETS IN ENUGU URBAN SOUTH EAST NIGERIA
OBJECTIVES:
The study investigated the local retail drug market to determine the prices, availability and affordability of antimalarial medicines to generate information for improving access to ACTs METHODS: A cross-sectional survey was conducted in retail outlets in Enugu urban SE Nigeria in 2011, based on WHO/HAI recommendations. Nine medicines from seven categories of antimalarial drugs were surveyed in a sample of 38 retail outlets, selected randomly by type and location. Data was collected by structured interviews, indepth interviews, and retail audits from both private retail pharmacies and patent medicine vendors. RESULTS: The market was highly characterized by a wide range of antimalarial medicines, averaging 10 brands per outlet. SPs and
